MCHCX Rating, Research - Blackrock Healthcare Inv C

Blackrock Healthcare Inv C (mchcx)

Last Updated by WikiWealth | Update This Page Now

►Summary | Add New Mutual Fund | Feedback

Short Term Rating Stock Ratings Help

Asset Allocation (% of Port)

US Stocks
Non-US Stocks

Geographic Allocation (% of Port)

North America
South America
Australia + Pacific Islands
Long Term Rating Stock Ratings Help


SWOT Statistics

Strengths + Opportunities = 64

Threats + Weaknesses = 56

When strengths & opportunities substantially exceed threats & weaknesses an investment in the mchcx mutual fund has great long term potential.

Fund Management Team

Fund Description Update

Blackrock Healthcare Inv C (MCHCX) Description: MCHCX is a mutual fund, which is an investment that owns a basket of assets. The MCHCX mutual fund was provided by Blackrock and this investment vehicle derives the majority of its value from equity holdings (stocks). Blackrocks mutual fund has a long management tenure and is in the small fund size classification. MCHCXs minimum initial investment amount is $1000 while the IRA minimum is $1000. MCHCXs expense ratio is roughly 2%. The latest MCHCXs front end load was 0% and the back end load was 1%. The Blackrock Healthcare Inv C (MCHCX) mutual fund falls under the health category. MCHCX focuses its investments in USA and MCHCX is focused on the health industry or fund sector. The Blackrock Healthcare Inv C (MCHCX) mutual fund is not a leveraged fund and it does not have inverse fund properties. An investor can find MCHCXs top holdings, fundamental analysis, ratings, and fund risk (volatility) on the left side of the screen. The right side of MCHCXs research report features technical analysis and long term investment potential.

Portfolio Strategy Update

This investment vehicle seeks long-term capital appreciation. The fund normally invests 80% of assets in healthcare companies that it believes have good prospects for earnings growth. These companies range from very large corporations to small, ??developmental stage? companies. The fund may invest without limit in foreign securities and in depositary receipts. It may also invest in convertible securities and rights. The funds non-diversified.

Management Analysis Update

Performance Analysis Update